Insight Molecular Diagnostics Inc.
IMDX- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001642380
No open-market purchases or sales by Insight Molecular Diagnostics Inc. insiders were filed in the last 90 days; 43 institutions reported holding it in 13F filings for Q3 2026, worth $66.6M in total; no superinvestor holds it.
13F holders, Q3 2026
Institutional positions in Insight Molecular Diagnostics Inc. as of Sep 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- +5 vs. Q2 2026
- Shares held
- 18.5M
- +567.1K (+3.2%) vs. Q2 2026
- Total value
- $66.6M
- −$39.5M (−37.2%) vs. Q2 2026
- New holders
- 13
- 12 more added
- Sold out
- 8
- 7 more reduced
2 institutions that held it in Q2 2026 haven't filed for Q3 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q3 2026 | 43 | $66.6M |
| Q2 2026 | 40 | $108.9M |
| Q1 2026 | 41 | $62.1M |
| Q4 2025 | 35 | $124.9M |
| Q3 2025 | 27 | $54.1M |
| Q2 2025 | 30 | $48.9M |
| Q1 2025 | 30 | $49.2M |
| Q4 2024 | 27 | $20.0M |
| Q3 2024 | 21 | $20.4M |
| Q2 2024 | 23 | $21.1M |
| Q1 2024 | 25 | $12.8M |
| Q4 2023 | 26 | $11.1M |
| Q3 2023 | 30 | $14.3M |
| Q2 2023 | 47 | $21.1M |
| Q1 2023 | 52 | $19.7M |
| Q4 2022 | 59 | $19.5M |
| Q3 2022 | 65 | $48.3M |
| Q2 2022 | 76 | $61.8M |
| Q1 2022 | 86 | $81.1M |
| Q4 2021 | 89 | $120.1M |
| Q3 2021 | 95 | $201.9M |
| Q2 2021 | 91 | $324.6M |
| Q1 2021 | 87 | $283.0M |
Institutions, Q3 2026
Shares, value and share of portfolio for each institution holding Insight Molecular Diagnostics Inc.; share changes are against Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Broadwood Capital Inc | 12,684,884 | $45.5M | 2.92% | 00.0% | Unchanged |
| AWM Investment Company, Inc. | 2,771,765 | $9.95M | 0.96% | −64,927−2.3% | Reduced |
| Vanguard Capital Management LLC | 731,391 | $2.63M | 0.00% | −4,456−0.6% | Reduced |
| Family Office Research LLC | 650,234 | $2.33M | 0.90% | +281,385+76.3% | Added |
| Geode Capital Management, LLC | 270,558 | $972.1K | 0.00% | +13,655+5.3% | Added |
| FNY Investment Advisers, LLC | 242,264 | $869.0K | 0.22% | +59,703+32.7% | Added |
| Two Sigma Investments, LP | 201,914 | $724.9K | 0.00% | +190,813+1,718.9% | Added |
| Vanguard Fiduciary Trust Co | 150,918 | $541.8K | 0.00% | +26,342+21.1% | Added |
| BlackRock, Inc. | 148,526 | $533.2K | 0.00% | −1,995−1.3% | Reduced |
| State Street Corp | 121,624 | $436.6K | 0.00% | +29,500+32.0% | Added |
| Walleye Capital LLC | 57,587 | $206.7K | 0.00% | +57,587 | New |
| Northern Trust Corp | 53,288 | $191.3K | 0.00% | +4,198+8.6% | Added |
| UBS Group AG | 44,872 | $161.1K | 0.00% | −8,404−15.8% | Reduced |
| Susquehanna International Group, LLP | 44,042 | $158.1K | 0.00% | +44,042 | New |
| Advisor Group Holdings, Inc. | 39,136 | $140.5K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 37,214 | $133.6K | 0.00% | +37,214 | New |
| Jane Street Group, LLC | 36,081 | $129.5K | 0.00% | −121,601−77.1% | Reduced |
| Jump Financial, LLC | 35,400 | $127.1K | 0.00% | +35,400 | New |
| Citadel Advisors LLC | 33,511 | $120.3K | 0.00% | +33,511 | New |
| Marshall Wace, LLP | 22,830 | $82.0K | 0.00% | +6,233+37.6% | Added |
| Zevenbergen Capital Investments LLC | 22,000 | $79.0K | 0.00% | +22,000 | New |
| Gsa Capital Partners LLP | 19,247 | $69.0K | 0.00% | +19,247 | New |
| Jefferies Financial Group Inc. | 18,100 | $65.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 17,544 | $63.0K | 0.00% | −17,971−50.6% | Reduced |
| Savvy Advisors, Inc. | 15,000 | $53.9K | 0.00% | +15,000 | New |
| Flatrock Wealth Partners LLC | 14,300 | $51.3K | 0.02% | +1,256+9.6% | Added |
| Vanguard Global Advisers, LLC | 12,918 | $46.4K | 0.00% | +7,143+123.7% | Added |
| Cerity Partners LLC | 11,947 | $42.9K | 0.00% | +11,947 | New |
| Private Advisor Group, LLC | 10,416 | $37.4K | 0.00% | 00.0% | Unchanged |
| Smith, Moore & Co. | 10,000 | $35.9K | 0.00% | +10,000 | New |
| BNP Paribas Arbitrage, SA | 9,540 | $34.2K | 0.00% | +3,739+64.5% | Added |
| EverSource Wealth Advisors, LLC | 5,000 | $17.9K | 0.00% | 00.0% | Unchanged |
| Transce3nd, LLC | 1,000 | $3.02K | 0.00% | +1,000 | New |
| Barclays PLC | 584 | $2.10K | 0.00% | +584 | New |
| JPMorgan Chase & Co | 309 | $1.04K | 0.00% | +155+100.6% | Added |
| SBI Securities Co., Ltd. | 185 | $664 | 0.00% | 00.0% | Unchanged |
| Golden State Equity Partners | 100 | $359 | 0.00% | +100 | New |
| Jones Financial Companies LLLP | 63 | $247 | 0.00% | 00.0% | Unchanged |
| Caitong International Asset Management Co., Ltd | 39 | $140 | 0.00% | −6−13.3% | Reduced |
| Piscataqua Savings Bank | 25 | $89 | 0.00% | 00.0% | Unchanged |
| Albion Financial Group | 7 | $26 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 7 | $25 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 1 | $4 | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 0 | $0 | 0.00% | −82,499−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −14,029−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −13,407−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −10,743−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −2,691−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −1,960−100.0% | Sold out |
| Cassaday & Co Wealth Management LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Global Retirement Partners, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Pura Vida Investments, LLC | – | – | – | – | Not filed |
| Royal Bank of Canada | – | – | – | – | Not filed |